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Immunoglobulin molecules serve as humoral and cellular receptors of the immune 
response  by  their  capacity  to  bind  antigen  and  to  interact  with  other  biological 
substances. Considerable information concerning the antibody and effector functions 
of immunoglobulins has come from studies on the homogeneous (monoclonal) protein 
products of plasma-cell  and  related malignancies  (reviewed in  [1]).  Homogeneous 
immunoglobulins  that  interact  with  the  acid  polysaccharides  agaropectin  (2-4), 
carrageenan  (4),  or  heparin  (5-10)  have  been  identified  among  human  myeloma 
proteins  and  Waldenstr6m  macroglobulins.  The extent, specificity, and  functional 
significance of these interactions, however, are presently unknown. 
We have employed several types of immunochemical and physicochemical methods 
to demonstrate the interaction of certain monoclonal proteins of the major immuno- 
globulin class, IgG, with agar and/or heparins derived from several biologic sources. 
8 such proteins were identified among  100 monoclonal IgG proteins examined. The 
capacity of certain IgG proteins to distinguish molecular heterogeneity among hepa- 
rins was shown by the patterns of reactions with heparins of defined molecular form. 
These results  provide new  information concerning the  nature  and  extent of IgG- 
heparin interactions which, because of their distinct chemical specificity, may have 
potential physiological significance. 
Materials and Methods 
Materials.  Serum samples  containing monoclonal immunoglobulins were obtained from 
patients with multiple myeloma or benign monoclonal gammopathy. Pooled normal human 
IgG (Cohn Fraction II ),-globulin)  was obtained from Mann Research Laboratories, Mann 
Chemical Corp, Louisville, Ky. Commercial sources of heparin were as follows: sodium heparin 
derived from porcine intestinal  mucosa,  Riker Laboratories, Inc., Northridge, Calif.  (Lipo- 
Heparin), Abbott Diagnostics, Diagnostic Products, North Chicago, Ill. (Panheprin), and Inolex 
Corp., Biomedical Div., Glenwood, Ill. (Stage 14 heparin); sodium heparin derived from bovine 
lung, Upjohn Co., Kalamazoo, Mich. (Heparin Sodium Injection U.S.P.) and ICN Nutritional 
Biochemicals Corp., Cleveland, Ohio (Heparin-Sodium, 100 U/rag); 3H-labeled heparin (0.732 
mCi/mg), New England Nuclear, Boston, Mass. Mercuripapain, hog pepsin, DNA, and RNA 
were obtained from Worthington Biochemical  Corp., Freehold, N. J.; o-(+)-glucosamine free 
base, o-(+)-glucosamine HC1, and chondroitin sulfate,  ICN Nutritional Biochemicals Corp.; 
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glucuronic acid,  California  Foundation  for Biochemical  Research;  galactosamine  HCI and 
hyaluronic acid, Mann Research Laboratories; N-acetyl-o-glucosamine, Calbiochem-Behring 
Corp., American Hoechst Corp. San Diego, Calif.; dextran (Blue dextran 2000) and Sepharose 
4B, Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.; and polyethylene 
glycol 6000, Fisher Scientific Co., Pittsburgh, Pa. (Carbowax PEG 6000). 
Methods.  IgG proteins and other protein constituents were isolated from serum specimens 
by zone (block)  electrophoresis on polyvinyl chloride (Pevikon; KemaNord, Stockholm, Swe- 
den). Monocional IgG protein preparations consisted of ~85-95% homogeneous IgG as deter- 
mined by imrnunochemical analyses with monospecific anti-heavy chain and with anti-r and 
anti-~ light chain antisera.  IgG proteins were subclassified ailotypically or chemically on the 
basis  of analyses performed by Dr.  Arthur G.  Steinberg,  Case Western  Reserve University, 
Cleveland, Ohio and Dr. Blas Frangione, New York University Medical Center,  New York, 
respectively. The methods for the preparation and isolation from IgG of papain-derived Fc and 
Fab fragments, pepsin-derived F(ab')2 and F(ab') fragments, and heavy and light polypeptide 
chains were as described previously (11,  12). The absence of any remaining intact IgG in these 
preparations was confirmed immunochemically. Carbamylated and acetylated derivatives of 
IgG were prepared by use of potassium cyanate (13) and acetic anhydride (14), respectively. 
The methods for preparing multi-chain (macromolecular) rat skin heparin (relative molecular 
mass  [Mr]  I  >900,000),  the  chemically-derived  single-chain  form  (Mr  ~  60,000),  and  the 
enzymatically-derived depolymerized forms (designated "partial", >100,000 daltons, and "ex- 
tensive", >20,000 and 8,000-20,000 Mr) were as described (15-17). One sample of multi-chain 
rat skin heparin served as the source of the single-chain and depolymerized heparin components. 
The molecular weights of the depolymerized rat skin heparins were estimated by gel filtration 
through a column of Bio-Gel A  15M calibrated with heparin standards of 23,000,  10,000, and 
6,000 Mr (18) (kindly furnished by Dr. Robert D. Rosenberg, Harvard Medical School, Boston, 
Mass.)  and with the single-chain form of rat skin heparin.  Four samples of porcine intestine 
heparin of defined molecular weight and functional activity, also furnished by Dr. Rosenberg, 
consisted of two ~20,000-Mr species, one of high affinity and one of low affinity for antithrom- 
bin, and two ~ 7,000-Mr components, one of high affinity and one of low affinity for antithrom- 
bin (19, 20). 
Protein concentrations were determined  by a  modification of the Folin-Ciocalteu method 
(12), and heparin concentrations by the metachromasia at As0o  nm of Azure A dye (19). Optical 
density measurements were made using a Gilford speetrophotometer. 
Immunoelectrophoretic and immunodiffusion analyses were performed in 2% (wt:vol) agar 
or 1% (wt:vol) agarose gels prepared in a 20 mM sodium barbital buffer, pH 8.6, ionic strength 
0.02. For certain experiments, immunodiffusion analyses were performed in 1% (wt:vol) agarose 
gels prepared in a 50 mM sodium barbital buffer, pH 8.6, containing 3% polyethylene glycol 
6000. 
Electrophoretic analyses on cellulose acetate or agarose gel membranes were performed with 
a Microzone apparatus (Beckman Instruments, Inc., Fullerton, Calif.). Membranes were stained 
for protein or mucopolysaccharide by Ponceau S or toluidine blue (0.1% in 0.5% acetic acid), 
respectively. 
For affinity chromatography and solid-phase assay experiments, a monoelonal IgG protein 
was immobilized on cyanogen bromide-activated Sepharose 4B (21) at an initial ratio of 1.7 mg 
of protein:l  ml  of gel,  as  determined  by measuring  the  amount  of protein  that  remained 
uncoupled. Sepharose, similarly activated under alkaline conditions by cyanogen bromide and 
then rendered inactive by treatment with ethanolamine, served as a control for affinity column 
and solid-phase assays. Scatchard plots (22) of IgG-heparin associations were constructed from 
data obtained by adding a constant amount of 3H-labeled heparin  (105 cpm) and increasing 
amounts of bovine lung heparin to 0.24-ml samples of IgG-Sepharose gel (containing 0.40 g of 
protein)  or 0.24  ml  of ethanolamine-Sepharose  gel  suspended  in  2  ml  of 25  mM  sodium 
phosphate buffer, pH  7.4. The samples were agitated occasionally during a  16-h incubation 
period  at  7,  23,  32,  and  56°C,  centrifuged  at  300 g  for 5  min  in  a  temperature-controlled 
centrifuge, and the radioactivity of the supernatant fluid determined. Data points were derived 
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from the averages of triplicate samples for each concentration of heparin minus the nonspecific 
adsorption of heparin by the ethanolamine-Sepharose control samples. 
Diafittration analyses (23) of heparin-IgG binding behavior were performed using an Amicon 
Model 8MC ultrafihration chamber equipped with an XM100A membrane (Amicon Corp., 
Scientific Sys.  Div., Lexington, Mass.)  (cut-off level,  M, ~ 100,000).  Bovine lung heparin  (10 
#g/ml) was infused as a constant rate into an ultrafiltration cell containing a 2-ml solution of 
IgG protein  (2  mg)  dissolved  in  a  25  mM  sodium  phosphate  buffer,  pH  7.4. The protein 
solution  was stirred  continually,  and  chamber pressure  (~5  lb/in  2)  maintained  to ensure  a 
constant  flow rate  of 6  ml/h.  After  100 #g of heparin  was  added  to  the  cell,  the  heparin 
concentration in the ultrafiltrate was measured by the metachromasia of Azure dye at As00 m. 
Results 
Recognition of Agar-binding Proteins.  Monoclonal IgG human immunoglobulins that 
interact  with  agar  were  recognized  by  the  characteristic  dense  white  precipitate 
formed in agar gels by serum specimens from certain patients with multiple myeloma 
or benign monoclonal gammopathy. For example, dui'ing the process of  serum analysis 
by immunoelectrophoresis,  a  dense,  white  rocket-shaped  precipitate,  located  imme- 
diately cathodal to the application well, appeared after electrophoresis but before the 
antiserum  trough was filled  (Fig.  1).  Although the location of the rocket precipitate 
corresponded  to that  of the subsequent  immune  precipitin  reactions,  the  relatively 
anodal electrophoretic mobility of the IgG proteins in the agar gel at pH 8.6 did not 
correspond to the more cathodal location of the proteins subjected to electrophoresis 
at the same pH either on a  cellulose acetate membrane or in an agarose gel. Further, 
no  precipitate  was  evident  immediately  after  electrophoresis  in  agarose  gels.  After 
fractionation  of serum  proteins  by  zone  electrophoresis,  only  the  IgG-containing 
fractions  formed precipitates  in  agar  gels  identical  to  those  observed  for the  whole 
serum.  Single  radial  diffusion  in  agar  gels  led  to  the  formation  of a  dense  white 
precipitin  ring  around  the  application  well,  which  had  a  diameter  proportional  in 
size to the concentration of IgG protein.  Although the isoelectric points of the agar- 
binding  IgG  proteins  were  typically  high  (as  shown  by  their  extreme  cathodal 
electrophoretic  mobility at  pH 8.6),  other monoclonal proteins of identical  mobility 
did not have this property. Six agar-binding IgG proteins were identified among 100 
monoclonal IgG-containing serum  specimens.  No agar-binding  proteins  were  found 
FIG.  1.  Precipitation of an IgG protein in a 2% agar gel. In this immunoelectrophoretic analysis 
of a serum specimen containing a monoclonal IgG~  protein (CA), a photograph of the reaction was 
obtained immediately after electrophoresis for 45 min at 50 V (0 h) and at the designated times (24 
h and 48 Ix) after the antiserum trough was filled with an anti-IgG antiserum. The locations of the 
polyclonal IgG-anti-IgG and the  monoclonal IgG-anti-IgG precipitin  reactions are indicated  by 
arrows on the 24-h and 48-h patterns, respectively. 886  IgG-SULFATED POLYSACCHARIDE INTERACTIONS 
in 26 serum specimens containing monoclonal IgA proteins or among 20 with IgM, 
5 with IgD, and  1 with IgE monoclonal proteins. 
IgG-Agar Interaction.  The extent of precipitation of IgG proteins in agar gels was 
influenced by ionic strength and temperature; no precipitate formed in gels containing 
>50 mM NaC1 and the precipitate was denser in those slides incubated at 7°(2 than 
in those incubated at 37°C. Precipitation with agar occurred with the pepsin-derived 
F(ab')2 fragment but not with F(ab'), the papain-derived Fc or Fab fragments, or the 
isolated heavy or light chains. 
Recognition of Heparin-binding IgG Proteins.  Because some IgG proteins precipitated 
in agar but not in agarose, the presence of the acidic polysaccharide constituent of 
agar,  agaropectin  (24),  was  implicated  as  the  cause  of this  interaction.  Another 
interacting  ligand,  heparin,  was  found  by  testing  the  capability  of  serum  CH 
(containing an agar-binding monoclonal IgG protein) to form precipitin-like reactions 
with other hexoses, hexosamines, and acidic macromolecules. When serum CH was 
tested  by comparative double-diffusion analyses in  1%  agarose gels containing 3% 
polyethylene glycol 6000  (25)  against chondroitin sulfate, dextran, DNA, galactosa- 
mine, glucosamine, glueosaminic acid, n-(+)-glucosamine HC1, glucuronic acid, hep- 
arin,  hyaluronie  acid,  and  RNA  (in  concentrations  from  0.15  to  5.0  mg/ml),  a 
precipitin-like reaction was  obtained only with  heparin.  That  the monoclonal IgG 
protein contained in serum CH was solely responsible for the reaction with heparin 
was readily demonstrated by double diffusion and immunoelectrophoretic analyses in 
agarose gels (Fig. 2). 
Among 100 monoelonal IgG-containing serum specimens, 8 formed preeipitin-like 
reactions with heparin (including 5 of 6 serums which reacted with agar) and, in each 
case,  the  reaction  could  be  localized  to  the  monoclonal  IgG  protein.  The  three 
additional heparin-binding IgG proteins did not bind agar but only one agar-binding 
protein failed to bind heparin. 
FIG. 2.  Demonstration  ofheparin-IgG inter~tction  in 1% agarose gels containing 3% polyethylene 
glycol 6000. (a) Double-diffusion  analysis: the central well contained serum specimen  CH and the 
six outer wells (1, 2, 3, 4, 5, and 6) contained  sodium heparin derived  from porcine  intestinal mucosa 
at concentrations  of 5.0, 2.5, 1.3, 0.6, 0.3, and 0.1 mg/ml, respectively.  Co) Immunoelectrophoresis: 
the antigen well contained  serum specimen  CH and the upper and lower  antisera troughs  contained 
bovine lung heparin (4.0 mg/ml) and an anti-IgG antiserum, respectively. DAVID E. LEVY, ALAN A. HORNER, AND ALAN SOLOMON  887 
Heparin-IgG Interaction in Agarose Gels.  The presence of both heparin and protein in 
the preeipitin-like lines  formed in agarose gels was confirmed by staining duplicate 
gels with toluidine blue and Coomassie blue, respectively.  This reaction between the 
IgG  proteins  and  heparin  was  visualized  after  16-24  h  at  7°C;  however,  when 
commercial (pharmacologic) sources of bovine lung or porcine intestine heparin were 
used, the lines disappeared at 37°C or when washed in solutions containing >50 mM 
NaC1. In contrast, the reaction with rat skin heparin occurred at 37°C and was stable 
under physiological conditions. 
All eight IgG proteins formed precipitin-like reactions in agarose gels with each of 
the heparin preparations tested. The nature of these reactions was markedly different, 
depending on the source and molecular form of the heparin (Fig. 3). The precipitin- 
like  reactions  between  IgG proteins  and  three  different pharmacologic sources  of 
heparins derived from bovine lung or porcine intestinal mucosa were less sharp and 
only partially identical to those obtained with multi-chain rat skin heparin (Fig. 3 A). 
Furthermore, multiple precipitin-like bands resulted from interactions between the 
IgG proteins and some commercial heparin preparations. The bands formed from the 
interaction of the IgG proteins with multi-chain rat skin heparin and with single- 
chain rat skin  heparin gave reactions of identity; the precipitin-like reaction of the 
commercial heparins were  also only partially identical to those of the single-chain 
species (Fig. 3 B). The partially depolymerized ~50,000-Mr  form was distinguishable 
from the more extensively depolymerized ~20,000-Mr  species (Fig. 3 C). The precipi- 
tin-like reaction given by the lower molecular weight component was comparable to 
that  of commercial porcine heparin.  One of the two precipitin-like bands  formed 
between IgG and porcine heparin gave a reaction of partial identity with the band 
formed between IgG and the ~20,000-M~ depolymerized rat skin heparin. The IgG 
proteins could also differentiate between the porcine heparins of defined molecular 
weight; the reactions given by the 7,000-M, material were partially identical to those 
of the 20,000-M, species (Fig. 3 D). The reactions of the IgG proteins with heparins of 
comparable  molecular weight  having high or  low  affinity for antithrombin were 
identical. 
Precipitin-like reactions of protein CA with both types of rat skin heparins (but not 
with  the commerical heparins)  were  evident after bovine lung heparin  had  been 
added to serum CA; no reactions with commercial or rat skin heparins occurred after 
addition of multi-chain rat skin heparin. 
Demonstration of  Heparin Binding by IgG Proteins.  An interaction between heparin and 
IgG  could  be  demonstrated electrophoretically at  a  pH  of 3.0  to  maximize the 
electrophoretic differences  of the two constituents (15). Protein CA combined with 
increasing amounts of  heparin gave protein-mucopolysaccharide  complexes of  increas- 
ingly anodal electrophoretic mobilities.  Under comparable conditions, no complexes 
resulted when polyclonal IgG was substituted for protein CA. 
Heparin-IgG interaction could also be shown by diafiltration experiments employ- 
ing membranes which almost completely prevented the passage  of IgG and yet only 
slightly impeded  the  flow  of heparin.  Three  monoclonal IgG proteins  of similar 
electrophoretic mobility were studied: an agar- and heparin-binding protein (protein 
CA), a heparin-binding protein (protein MA), and a protein that bound neither agar 
nor heparin (protein BR). Under comparable conditions, heparin was retained only 
in the ultrafiltration cells containing proteins MA and CA. The amounts of heparin FIG.  3.  Comparison  of the  interactions in agarose  gels of monoclonal  IgG-containing  sera  with 
preparations of bovine, porcine, and rat skin heparins. The center well in each pattern contained 
serum specimens CA or CAR as indicated; the concentration of the monoclonal IgG protein in each 
serum was  ~30 mg/ml.  (A) The outer wells  1 and 4  contained multi-chain  (macromolecular)  rat 
skin heparin  (2.5  mg/ml);  well 2, bovine lung heparin, Upjohn Co.  (0.3 mg/ml);  well 3, Stage  14 
heparin,  Inolex  Corp.,  Biomedical  Div.  (0.3  mg/ml);  well  5,  porcine  intestine  heparin,  Abbott 
Laboratories  (0.3  mg/ml);  and well 6,  bovine lung heparin,  ICN  Nutritional  Biochemicals Corp. 
(1  mg/ml),  (B) The outer wells  I  and 4 contained multi-chain rat skin heparin  (2.5 mg/ml);  wells 
2  and 5, single-chain rat skin heparin  (2.5  mg/ml);  well 3, porcine intestine heparin  (0.3 mg/ml); 
and well 6, bovine lung heparin  (1  mg/ml).  (C) The outer wells  1 and 4 contained single-chain rat 
skin heparin  (2.5 mg/ml); well 2, partially depolymerized heparin (Mr ~  50,000,  1 mg/ml); wells 3 
and  5, extensively  depolymerized  heparin  (Mr ~  20,000,  1 mg/ml);  and  wel| 6, porcine intestine 
heparin (0.3 mg/ml).  (I3) The outer wells  1 and 4 contained single-chain rat skin heparin (2.5 rag/ 
ml); well 2, high antithrombin affinity, low molecular weight porcine intestine heparin (Mr ~  7,000, 
0.7 mg/ml); well 3, high antithrombin affinity, high molecular weight porcine intestine heparin (Mr 
~  20,000,  0.7 mg/ml);  well 5, low antithrombin affinity, high molecular weight  porcine intestine 
heparin  (Mr ~  20,000,  0.7  mg/ml);  and  well 6,  low antithrombin  affinity,  low molecular  weight 
porcine intestine heparin  (Mr ~  7,000, 0.7 mg/ml). The  1% (wt:vol) agarose gels were prepared in 
a  50 mM sodium barbital buffer, pH 8.6, containing 3% polyethylene glycol 6000. 
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in the ultrafiltrate of cells containing either no protein (control) or proteins MA, CA, 
and BR were 29.4, 0.9, 4.0, and 35.4 #g, respectively. 
The binding of heparin by protein CA was also shown by affinity chromatography. 
1 ml of the protein CA-Sepharose column (protein density, 1.7 mg/ml of packed gel) 
bound ~200 #g of heparin, retaining virtually  100% of applied material as long as 
this amount was not exceeded. The same sites on the column bound both 3H-labeled 
and  unlabeled  heparin,  as evidenced by the  lack of further binding  of 3H-labeled 
heparin after pretreatment with an excess of unlabeled heparin (1 mg/ml of column 
volume). The bound heparin was completely eluted with 1 M  NaCI; only 55% of the 
heparin could be eluted with 0.15 M  NaC1. A Scatchard-type analysis of the binding 
at  7, 24, and 37°C to immobilized protein CA of 3H-labeled heparin and unlabeled 
bovine lung heparin revealed a biphasic curve. The association constant of the high- 
affinity sites was temperature sensitive (7°C,  1.3  X  10  s M-t;  24°C, 0.6 ×  10  s M-l; 
37°C, 0.3 X  l0  s M-l); the lower affinity sites were more numerous and less affected 
by increased temperature, and had a binding constant ~ 10% that of the high-affinity 
sites. 
The addition ofheparin to solutions of  certain IgG proteins altered the characteristic 
A2s0 ~  (but not A~o r~) as observed when heparin interacts with other proteins (26). 
Although  heparin alone has no absorbance at  this wavelength, a  sharp  increase in 
optical density of a  1 mg/ml  solution of protein  MA  occurred when  heparin  was 
added. The maximum effect was observed with ~50 #g of heparin per ml of protein 
solution  (Fig.  4).  No  changes  in  absorbance  occurred when  heparin  was  added  to 
solutions of polyclonal IgG or to solutions of the IgG protein BR (data not shown). 
Precipitation of IgG Proteins by Heparin.  Heparin  and  protein coprecipitated when 
heparin  was  added  to  solutions  of heparin-binding  IgG  proteins.  This  effect was 
quantitated  turbidimetrically at A~o ~,m by determining the protein content of the 
precipitate  or  supernate.  In  the  case  of serum,  a  decrease  in  concentration  after 
addition of heparin was documented by densitometry after analytical electrophoresis 
of the supernate. The precipitation by heparin of IgG proteins directly from serum 
A 
g 
0 
I  °  I  I  I  I 
l  -  ,  ]  ,  ]  *  ]  ~  ]  ,  I 
50  tOO  150  200  250 
HEPARIN  (/zq/ml) 
Fro.  4.  Ultraviolet absorbance of tgG. The absorbance of 1 mg/ml solutions of the monoclonal 
IgG protein MA (O) and polyclonal IgG (Fraction II ,/-globulin) (&) in a 25 mM sodium phosphate 
buffer, pH  7.4, was compared at A~0 ~.~ in the presence of varying concentrations of bovine lung 
heparin. The A  OD represents the percent difference in absorbance of the protein solutions after 
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was facilitated by adding 3% polyethylene glycol to the reaction mixture (25). The 
quantitative nature of the precipitin-like reactions of two heparin-binding proteins 
(CA and MA) is illustrated in Fig. 5. 
The amounts of proteins CA and MA precipitated by bovine lung heparin were 
affected by the  ionic strength and temperature of the reaction mixture. Maximum 
precipitation occurred  in solutions of low  ionic strength. As shown in Table I,  the 
amount of protein MA precipitated by heparin decreased progressively as the ionic 
strength of the solution was increased by the addition of NaC1. When the temperature 
was  increased from  7  to  24°C,  the  extent  of protein precipitated  by heparin also 
decreased.  The  addition of urea  to  a  final concentration of either  3  or  6  M  to  a 
solution of protein CA and heparin  (in 25  mM  sodium phosphate  buffer, pH  7.4) 
produced  a  28  and  a  47%  inhibition, respectively,  of  protein  precipitation.  The 
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Fta.  5.  Precipitation of monocLonal  IgG proteins by heparin. 100/.~g of the IgG proteins CA (0), 
MA (&), and BR (B) in a 50 mM sodium phosphate buffer, pH 7.4, containing 4% polyethylene 
glycol 6000, were incubated for  15 min at 7°C with 0.7, 13.5, 27, 54, or 270/tg of bovine lung 
heparin. The samples were centrifuged at 300 g for 5 min and the resulting precipitates were washed 
three  times with  the  buffer solution, dissolved in  l  M  NaOH,  and  the  protein content  was 
determined. 
TABLE  I 
Effect of lonic Strength  on Precipitation  of lgG by Heparin 
Inhibition of 
NaCI  Protein precipitated*  precipitation 
mM  p.g  % 
--  71  0 
25  53  25 
50  50  29 
75  37  47 
125  23  67 
* The complete reaction mixtures (1 ml) contained 25 mM sodium phosphate 
buffer, pH 7.4, 4% polyethylene glycol 6000, 13.5/Lg bovine lung heparin, 
100/.tg IgG protein MA, and concentrations of NaCI from 25 to 125 mM. 
Each mixture was incubated at 7°C for 15 rain, centrifuged at 300 g for 5 
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precipitation  of protein  CA  by  both  chain  forms of rat  skin  heparin,  but  not  by 
commerical  sources  of bovine  lung or  porcine  intestinal  heparin,  occurred  under 
physiological conditions of ionic strength and temperature. When ionic strength was 
increased  by  adding  NaCI  in  concentrations  from  25  to  150  mM  or  when  the 
temperature was raised from 7 to 24°C, the precipitation of IgG by multi-chain rat 
skin heparin decreased by <25%. 
The interaction of monoclonal IgG proteins with the acid polysaccharides heparin 
and agaropectin was not affected by chemical reduction and alkylation of the native 
IgG  molecule.  Carbamylation  or  acetylation  of the  IgG  protein  CA  reduced  its 
positive charge and abolished its capability to bind heparin (and agar). 
Localization  on the IgG Molecule of the Heparin-binding  Site.  The Fab (but not the Fc) 
fragments of proteins CA and MA were precipitated by the multi-chain and single- 
chain rat skin heparins. Further, the dimeric fragment F(ab')2 of protein MA retained 
its heparin-binding reactivity, giving a precipitin curve similar to the intact molecule 
(Fig.  5).  Immobilized  bovine  lung heparin  was the  ligand  used  to  investigate  the 
heparin-binding capacity of the pepsin-derived dimerie and monomeric fragments of 
protein MA. The data for the F(ab')2 and F(ab') fragments of protein MA (Table II) 
indicate that both components retained their heparin-binding activity; reduction of 
the dimeric F(ab')2  fragment of protein MA to the F(ab') monomer led to decreased 
TABLE  II 
Binding of a Monoclonal IgG Protein and Its Pepsin-derived  Fragments to 
Immobilized Heparin 
Amount  Amount bound to heparin-  Protein  added*  Sepharose 
#g  #g  % 
30  25*  83 
40  35  88 
90  70  78 
170  120  71 
400  210  53 
F(ab')2  50  40  80 
60  40  67 
120  90  75 
225  110  49 
F(ab')  60  40  67 
90  60  67 
150  90  60 
260  90  35 
* Designated  amounts of the native IgG protein MA and its dimeric F(ab')2 
and monomeric F(ab') pepsin-derived fragments were incubated at 7°C for 
15  min  with  0.5  ml  of bovine  lung  heparin-Sepharose  or  ethanolamine- 
Sepharose in a  50 mM sodium phosphate buffer, pH 7.4. The samples were 
centrifuged  at  300  g  for  5  min  and  the  protein  concentrations  in  the 
supernatant fluids were measured. 
Corrected for nonspecific absorption of heparin to ethanolamine-substituted 
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precipitation with heparin.  In contrast with the intact protein, the Fab fragments of 
certain IgG proteins (e.g., CA and CH) were not precipitated by commercial heparins. 
Characteristics of Representative IgG Proteins.  Several immunochemical and physico- 
chemical properties of 11  monoclonal IgG proteins were studied (Table III). Six of 
the  nine  agar-/heparin-binding  proteins  were  of the  IgG1  subclass.  Activity was 
independent  of the  [gG  light  chain  type,  solubility  property,  or  electrophoretic 
mobility. Euglobulins may precipitate nonimmunologically with acid polysaccharides 
(3). Although proteins MA, SU; and GO are not euglobulins, they also bound heparin 
or agar; conversely, the euglobuli~ protein BO bound neither.  Evidence for a cross- 
reacting  idiotypic  determinant  (27)  among  the  heparin-binding  IgG proteins was 
obtained with an anti-idiotypic antiserum prepared against the crystallizable mono- 
clonal IgG heparin-binding protein DOB (6). By immunodiffusion analyses, the eight 
heparin-binding  IgG proteins each formed a  precipitin reaction with the anti-DOB 
antiserum  (kindly supplied by Dr.  Lisa A. Steiner, Massachusetts Institute of Tech- 
nology, Cambridge, Mass.), which had been absorbed extensively with pooled normal 
IgG  (Cohn  Fraction  II)  or with  monoclonal  IgG  proteins  of the  same VH  region 
subgroup (VnIII) as protein DOB (28). When tested in similar fashion, this antiserum 
did not react with any of 52 non-heparin-binding  monoclonal IgG proteins (see Fig. 
6 for representative analysis). Further, the precipitin reactions between the anti-DOB 
antiserum and the heparin-binding IgG proteins CA and CAR were inhibited by the 
presence  in  agarose  gels  of multi-chain  rat  skin  heparin;  by contrast  and  under 
identical conditions, heparin  did not affect the precipitin reactions between proteins 
CA and CAR and an antiserum prepared against the Fc fragment of Cohn Fraction 
II IgG. 
Discussion 
The interaction of 6 of 100 monoclonal IgG proteins with agaropectin, the highly 
acidic sulfated polysaccharide constituent of agar (24), was implicated by the precip- 
TABLE  III 
Immunochemical, Physicochemical, and Functional Properties of Selected Monoclonal IgG Proteins 
Electropho-  Reactivity 
IgG protein  Heavy chain  Light  Euglobulin  retic mobil- 
subclass  chain type  property*  ity:~  Agar  Heparin§ 
CA  71  x  I  -2.0  +  + 
CAR  ya  X  I  -  1.6  0  + 
CH  "fl  K  I  -2.2  +  + 
BO  ND][  K  I  -0.7  0  0 
BR  yl  ~k  S  -- 1.8  0  0 
GO  ND  x  S  -  1.6  +  0 
LE  ya  ~  S  -0.5  0  + 
MA  y]  h.  S  -  1.4  0  + 
OA  "tl  K  I  -2.2  +  + 
SU  y1  K  S  -  1.6  +  + 
VA  "t~  r  I  -2.2  +  + 
* Solubility of IgG protein in deionized, distilled water: S, soluble; I, insoluble. 
Distance  from  application  site  after  electrophoresis  on  an  agarose  gel  membrane  in  25  mM  sodium 
barbital buffer, pH 8.6, for 100 min at  150 V. 
§ Bovine lung heparin. 
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Fxo. 6.  Demonstration  of cross-reacting  idiotype  among heparin-binding IgG proteins. Imunodif- 
fusion analyses in agar gels of monoclonal  heparin-binding  proteins (1 mg/ml) IgGr CA, IgG~¢ VA, 
and IgGA  CAR and non-heparin-binding  proteins IgGK  TIL, IgGA BR, and IgGA MeG. (Left)  The 
center well contained a monospecific  anti-IgG antiserum. (Right) The center well contained an 
antiserum which was prepared against the heparin-binding IgG protein DOB (6, 28) and absorbed 
with Cohn Fraction II y-globulin. The 2% (wt:vol) agar gels were prepared in a 20 mM sodium 
barbital buffer, pH 8.6, containing 3% polyethylene  glycol  6000. 
itation and anomalous electrophoretic behavior of such proteins in agar but not in 
agarose.  This  interaction  involved the  divalent  F(ab')2  molecule;  no  precipitation 
occurred with monovalent F(ab'), Fab, or Fc fragments, or with the isolated heavy or 
light chains of the agar-binding IgG proteins. 
Another acidic polysaccharide, heparin, was identified as a ligand interacting with 
five  of the  six  agar-binding  IgG  proteins  and  with  three  non-agar-binding  IgG 
proteins. The interaction between heparin and IgG resulted from a binding between 
the two compounds and was not attributable to a solvent-exclusion effect (29) by the 
polyanionic  carbohydrate  that  would  have  allowed  only  protein  to  precipitate. 
Heparin-IgG interaction was also demonstrated through other studies, including: the 
quantitative precipitation of IgG by heparin;  the electrophoretic demonstration of 
mucopolysaccharide-protein complexes; the prevention by IgG of the ultrafiltration 
of heparin  through  membranes  of appropriate  permeability;  the  enhancement  by 
heparin of the optical  density at  A2a0 m  of IgG;  and  affinity chromatography and 
solid-phase assays. 
The  binding  of heparin  by  human  monoclonal  immunoglobulins  has  been  at- 
tributed to antibody specificity of the proteins for heparin  (5-10). This interaction 
can  also  result  from  salt  bonding  between  the  acidic  polysaccharide heparin  (or 
agaropectin)  and certain positively charged IgG proteins. All heparin-binding mon- 
oclonal  IgO  proteins  so  far  detected  have  had  relatively  high  isoelectric  points; 
desulfation  of heparin  results  in  loss  of  reactivity  with  IgG  (10).  Although  the 
complementarity of charge  between  the  basic  IgG  protein  and  the  acidic  ligands 
suggests an electrostatic interaction, other monoclonal IgG proteins, e.g., protein BR 
(Table III), had equivalent electrophoretic mobilities at pH 8.6 and yet failed to bind 
heparin  (or agar).  Heparin-IgG interactions were also demonstrable at  a  pH of 10 
when the IgG molecule was present as a negatively charged species. Thus, the overall 
charge of the protein cannot  be the sole explantation  for this  interaction.  It  may, 
instead, represent only one criterion for binding which requires, in addition, a specific 
IgG conformation  (or charge distribution),  as  occurs for induced  antibodies  raised 
against  highly  charged  antigens  (30).  Studies  of model  systems  have  shown  that 
heparin affinity for other plasma proteins, e.g., anti-thrombin and lipoprotein lipase, 894  IgG-SULFATED POLYSACCHARIDE INTERACTIONS 
involves more specificity than just  the  presence of cationic groups on the  binding 
proteins (20, 29, 31, 32). 
Considerable  functional and  chemical heterogeneity among commercial heparin 
preparations has been documented through studies of the anti-coagulant and protein- 
binding  properties  of heparin  in  other  interacting  systems.  Heparins  vary in  the 
number of N-sulfated g!ucosamine moieties per mole, and can be fractionated into 
two distinct species based upon high and low affinity for antithrombin and on anti- 
coagulant  activity  (18-20,  31).  Heparin  prepared  from  rat  skin  is  a  multi-chain 
proteoglycan with Mr >900,000  (15)  and can  be converted chemically to a  single- 
chain  species with Mr ~60,000  (16)  or depolymerized enzymatically to material of 
molecular weights (7,000-25,000 Mr)  comparable to commercially available forms of 
heparin (17, 20). These structural differences may account for the capacity of heparin- 
binding IgG proteins to distinguish between the multi-chain and single-chain rat skin 
heparin preparations and the lower molecular weight depolymerized rat skin heparin 
or commercial heparins and between bovine and porcine heparins (see Fig. 3). Thus, 
subpopulations  of molecules within a  monoclonal IgG heparin-binding population 
may differentiate molecular species of heparin. 
The site(s) on the Fab portion of the IgG molecule involved in binding agaropectin 
or  heparin  has  not  been  definitely  established.  The  virtual  identity  in  primary 
structure of the heavy and light chain constant domains of monoclonal IgG proteins 
of the  same subclass  and  light  chain  type, respectively, and  the  demonstration of 
heparin-binding by monoclonal IgM  and  IgA proteins  (5-10)  implicate the  heavy 
and/or light chain variable (V) domains as the major site(s) of such interaction. The 
presence of common structural V  region similarities among our heparin-binding IgG 
proteins was evidenced immunochemically by the demonstration that these proteins 
share a cross-reactive idiotypic antigenic determinant (27)7 
None of the eight patients whose serum contained monoclonal heparin-binding IgG 
proteins had received heparin or had evident disorders of blood coagulation. That 
monoclonal heparin-binding IgG proteins may be a minor constituent of normal IgG 
and  have  functional  significance was  suggested  by our  demonstration  of heparin- 
binding IgG in serum specimens from two individuals who required, for anticoagu- 
lation, therapeutically inordinately large doses of heparin. In both cases, this activity 
was localized to relatively cathodally migrating, IgG-containing fractions. The phys- 
iological or pathological significance of heparin-IgG interactions is also evidenced by 
the molecular events associated with heparin-induced platelet aggregation  (34)  and 
thrombocytopenia (35). 
Because the nature of heparin-binding by certain IgG proteins appears similar to 
that  of other heparin-interacting proteins, the conformational changes  induced by 
such  binding  may also  allosterically affect  the  IgG  molecule, thus  influencing its 
function as a  humoral or cellular receptor. The availability of purified heparins of 
defined  chemical  and  biologic  specificity  and  of monoclonal  IgG  proteins  with 
2  Although the heparin-binding protein DOB has a deletion of 15 residues in the hinge region of the 
heavy chain and lacks heavy-light  interehain disulfide  bridges (28), features  of the Vn sequence  that might 
account for this activity are not as yet evident. The deletion  of the hinge region is not likely  associated with 
heparin-binding because none of our IgG proteins are known to share this feature and, further, the IgG 
protein MeG (kindly supplied by Dr. Allen B. Edmundson, University  of Utah, Salt Lake City, Utah), 
which contains an identical 15-residue  hinge region deletion (33), is devoid of heparin-binding activity. DAVID E.  LEVY, ALAN A.  HORNER,  AND ALAN SOLOMON  895 
heparin-binding  properties should  provide the material necessary to define  further 
the structural basis and biological significance of these interactions. 
Summary 
The interaction of immunoglobulins with certain acidic polysaccharides was dem- 
onstrated by the binding of the sulfated glycans agaropectin and heparin by certain 
human  IgG  proteins.  Heparin-binding  IgG  proteins  can  distinguish  between  the 
molecular forms of heparin derived from porcine intestine, bovine lung, and rat skin. 
The major specificity of these proteins is for native and certain high molecular weight 
subunit components of rat skin heparin. The interactions with multi-chain and single- 
chain rat skin heparin are stable under physiological conditions and involve the Fab 
and, more specifically, the Fv region of the IgG molecule. These reactions occur as a 
result of an electrostatic interaction between cationic sites on certain IgG proteins and 
anionic sulfate residues of agaropectin or heparin. The characteristics of heparin-IgG 
interaction resemble those of heparin with other plasma proteins, the interactions of 
which have biological significance. 
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